Brand

Five things for pharma marketers to know: Wednesday, December 6, 2017

Five things for pharma marketers to know: Wednesday, December 6, 2017

By

FDA approves Novo's diabetes drug; Walgreens undergoes rebranding in the wake of CVS-Aetna merger; pharma increasingly transparent about clinical trial data

P&G slashed the number of sites it ran ads on by nearly 70% after YouTube brand safety scandal

P&G slashed the number of sites it ran ads on by nearly 70% after YouTube brand safety scandal

By

In April, a month or so after brands were accused of funding terrorist videos on YouTube, Procter & Gamble cut down the number of sites its ads ran on by 69%.

Porter Novelli wins lucrative multi-year CSR brief with Johnson & Johnson

Porter Novelli wins lucrative multi-year CSR brief with Johnson & Johnson

By

Porter Novelli has been appointed to lead a new global CSR brief for pharma and consumer goods giant Johnson & Johnson, as the company faces a major reputation challenge in the US.

American Cancer Society: 'We are more than just a research organization'

American Cancer Society: 'We are more than just a research organization'

By

The new brand campaign, Attacking Cancer from Every Angle, showcases all the services the organization provides.

Is your brand's voice, male, female, human or mineral?

Is your brand's voice, male, female, human or mineral?

By

The rise of voice technology platforms and the connected home has turned the discussion of a brand's voice from metaphorical to physical.

Giant brings on new brand experience lead, as Armstrong departs

Giant brings on new brand experience lead, as Armstrong departs

By

Aaron Sklar, formerly of Welltok, replaces Christine Armstrong, who moved on to a Silicon Valley health startup.

How Lauren Schulz is shaping Dr. Reddy's OTC brands

How Lauren Schulz is shaping Dr. Reddy's OTC brands

By

She is director of OTC brand marketing at Dr. Reddy's Laboratories.

Top 25 oncology brands in 2016, based on U.S. sales

Top 25 oncology brands in 2016, based on U.S. sales

By

Celgene's Revlimid tops the list, according to data compiled by EvaluatePharma.

Twitter launches DM cards for brands

Twitter launches DM cards for brands

Twitter has launched a customizable Direct Message Card that brands can use to promote and share the bots or other customer experiences they've created, while Snapchat and Instagram have launched stories updates.

Regeneron uses VR to humanize retinal disease

Regeneron uses VR to humanize retinal disease

By

The drugmaker saw a gap in patient-physician conversation about retinal disease.

From SXSW: Learnings for Healthcare Marketers from the NYT and WWE

From SXSW: Learnings for Healthcare Marketers from the NYT and WWE

As we build health solutions, making decisions in office parks and around conference tables, it's easy to lose the individual person through the scale of our work.

How To Make A Doctor Happy: Take Away the Brand Message in a Drug Ad

How To Make A Doctor Happy: Take Away the Brand Message in a Drug Ad

The presumption is Dr. A saw ad B, clicked on it, went to the site and within C time, prescribed product D.

4 Ways Marketers Can Create Valuable Content That Achieves Brand Objectives

4 Ways Marketers Can Create Valuable Content That Achieves Brand Objectives

"Find exactly what your audience wants, find exactly where they spend their time, and deliver."

Pfizer creates app for patients with depression

Pfizer creates app for patients with depression

By

The connection to Pristiq is not overt in the app's user interface, though Moodivator is featured on Pristiq's website.

An EHR strategy can't be measured in clicks, says Lilly exec

An EHR strategy can't be measured in clicks, says Lilly exec

By

Pharma can reach physicians within the EHR, but they must send the right message at the right time, she said at an MM&M event.

Lilly's branded app for Trulicity looks to address adherence

Lilly's branded app for Trulicity looks to address adherence

By

Companies such as Eli Lilly and Medtronic have launched branded apps for their products, but experts say they don't make sense for all medicines.

The 50-plus consumer is driven by curiosity and wonder, finds Ketchum study

The 50-plus consumer is driven by curiosity and wonder, finds Ketchum study

By

In the United States, people over 50 are often stereotyped as complacent, set in their ways and extremely loyal to their preferred brands, but a new study released Tuesday by Ketchum found that the opposite is true.

Best Branded Website for Healthcare Professionals of 2016

Best Branded Website for Healthcare Professionals of 2016

By

CDM New York populated this engaging and outstanding website for Salix with unique visuals and messaging elements designed to drive awareness.

Podcast: Adherence: Leveraging Data to Enhance Your Brand's Ability to Reach Target Patients

Podcast: Adherence: Leveraging Data to Enhance Your Brand's Ability to Reach Target Patients

In this sponsored podcast, MM&M's Larry Dobrow speaks with Robert Leedom, senior analytics consultant at TrialCard, and Paul LeVine, VP of analytic services for TrialCard, about how to reach patients by leveraging brand data.

Five things for pharma marketers to know: Wednesday, September 14, 2016

Five things for pharma marketers to know: Wednesday, September 14, 2016

By

Patients who ask for a prescription after seeing an ad are more likely to get one; Mylan's executive pay is now under scrutiny

Mylan's branded ad spending on the EpiPen rose 357% — to $43 million in 2015 — over five years

Mylan's branded ad spending on the EpiPen rose 357% — to $43 million in 2015 — over five years

By

In 2011 the drugmaker spent $9.4 million on branded ads for the EpiPen. By 2015, branded ad spending hit $43 million.

The co-pay card debate simmers, as payers push back

The co-pay card debate simmers, as payers push back

By

Will this payer pressure pose an existential threat to co-pay cards even though patients love them?

Five things for pharma marketers to know: Friday, July 15, 2016

Five things for pharma marketers to know: Friday, July 15, 2016

By

PhRMA brings on new members, Amgen partners with Daiichi Sankyo on biosimilar commercialization in Japan; Thomson Reuters to sell science unit

Can pharma movement campaigns flourish on both sides of the Atlantic?

Can pharma movement campaigns flourish on both sides of the Atlantic?

By

Executives attending Cannes Lions Health weigh in on the imbalance seen in the U.S. between branded and unbranded drug ads.

Cannes: The Heat Is On

Cannes: The Heat Is On

By

A rundown of MM&M at Cannes, and five burning questions heading into the Lions Health festival and awards.

Balancing Opportunity and Responsibility in Healthcare Targeting

Balancing Opportunity and Responsibility in Healthcare Targeting

If you truly understand who your high writers and compliant patients are, you'll understand when and how to communicate with prospects that look and act like them.

What Brand Won the Super Bowl of Pharma?

What Brand Won the Super Bowl of Pharma?

Pharma marketers are wondering if these exorbitant media buys ($4.9 million for 30 seconds) were worth the investment for Valeant and AstraZeneca. Was either strategy successful?

Urhekar, in biggest move yet as Americas president, unites McCann Health NA agencies

Urhekar, in biggest move yet as Americas president, unites McCann Health NA agencies

By

IPG's McCann Health announces branding and operational changes aimed at integrating its US and Canadian shops.

Five things for pharma marketers to know: November 11, 2015

Five things for pharma marketers to know: November 11, 2015

By

Dr. Reddy's is blocked from selling generic purple Nexium; the FDA approves Roche's melanoma drug; Novartis says Entresto keeps heart-failure patients from being readmitted to the hospital

An Open Letter: Allowing Regional Flexibility Bolsters Global Branding

An Open Letter: Allowing Regional Flexibility Bolsters Global Branding

We're not out to reinvent the wheel if we don't have to but we will need to localize the campaign for New Zealand and do what is right for our physicians and our patients.